8-K: Teladoc Health Q3 2026: Revenue Dips, Adjusted EBITDA Rises

Teladoc Health reported a 3% year-over-year revenue decrease to $605.1 million for Q3 2026, alongside a net loss of $26.9 million, but saw a 14% increase in Adjusted EBITDA to $79.4 million.

Summary

• For the third quarter of 2026, Teladoc Health reported revenue of $605.1 million, a 3% decrease compared to the same period in 2025.
• The company incurred a net loss of $26.9 million, or $0.15 per share, an improvement from a net loss of $49.5 million, or $0.28 per share, in Q3 2025.
• Adjusted EBITDA increased by 14% year-over-year to $79.4 million.
• The Integrated Care segment revenue grew 2% to $398.5 million with an adjusted EBITDA margin of 18.8%.
• The BetterHelp segment revenue decreased by 13% to $206.6 million, with an adjusted EBITDA margin of 2.2%.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mixed financial report. While Adjusted EBITDA and Integrated Care segment performance show improvement, overall revenue and net loss remain concerning, with significant declines in the BetterHelp segment's out-of-pocket revenue.

Positives

• Adjusted EBITDA increased by 14% to $79.4 million in Q3 2026.
• Integrated Care segment revenue grew by 2% to $398.5 million.
• Integrated Care segment adjusted EBITDA margin improved to 18.8%.
• Net loss per share improved to $(0.15) from $(0.28) in the prior year's quarter.
• Cash flow from operations increased to $106.5 million in Q3 2026 from $99.3 million in Q3 2025.
• Free cash flow increased to $75.9 million in Q3 2026 from $67.9 million in Q3 2025.

Negatives

• Total revenue decreased by 3% to $605.1 million in Q3 2026.
• BetterHelp segment revenue decreased by 13% to $206.6 million.
• BetterHelp segment adjusted EBITDA margin decreased to 2.2%.
• Access fees revenue decreased by 10% to $466.7 million.
• U.S. revenue decreased by 4% to $489.2 million.

Risks

• Changes in laws and regulations applicable to the business model.
• Changes in market conditions and receptivity to services, including competition.
• Loss of key clients or a significant number of members or BetterHelp paying users.
• Decrease in revenue from users paying out-of-pocket without offsetting growth in insurance-covered services in the BetterHelp segment.
• Changes in the ability to recruit and retain qualified providers.
• Potential impairment losses with respect to goodwill or other assets.
• The performance of new products, including Teladoc One.
• The rate and magnitude of declines in BetterHelp cash-pay users and revenue.

Future Outlook

For the full year 2026, the company expects revenue between $2,395 million and $2,441 million, Adjusted EBITDA between $277 million and $303 million, net loss per share between $(0.95) and $(0.75), and Free Cash Flow between $135 million and $165 million. For the fourth quarter of 2026, revenue is projected to be between $569 million and $615 million, and Adjusted EBITDA between $74 million and $100 million.

Management Comments

• "We delivered third quarter results near the upper end of our guidance range for consolidated revenue and above our range for consolidated adjusted EBITDA, reflecting solid execution across our two segments," said Chuck Divita, Chief Executive Officer of Teladoc Health.
• "Within the Integrated Care segment, we continue to advance our innovation agenda, including the implementation of Teladoc One with our early launch partners, while also expanding our capabilities through initiatives such as hybrid care and AI-enabled solutions."
• "In the BetterHelp segment, insurance revenue exceeded our expectations, and we are making encouraging progress expanding provider capacity and scaling access to covered services."
• "While there is more work ahead, we remain focused on disciplined execution against our strategic priorities. The actions we are taking are showing traction, and we believe will position us well for the opportunities ahead."

Industry Context

StockSavvy.ai notes that Teladoc Health's results reflect ongoing challenges in the virtual care market, particularly within direct-to-consumer mental health services like BetterHelp, which is experiencing a decline in out-of-pocket users. The growth in the Integrated Care segment, however, aligns with broader industry trends towards more integrated and hybrid healthcare models.

Stakeholder Impact

• Shareholders may be concerned by the continued overall revenue decline and net loss, despite improvements in Adjusted EBITDA.
• Employees may face uncertainty due to ongoing restructuring costs and the strategic shifts impacting the BetterHelp segment.
• Customers (patients) may see continued access to virtual care services, with a focus on integrated and insurance-covered options.

Next Steps

• Continue to advance innovation agenda in the Integrated Care segment, including Teladoc One implementation.
• Expand capabilities in Integrated Care through hybrid care and AI-enabled solutions.
• Focus on expanding provider capacity and scaling access to insurance-covered services in the BetterHelp segment.
• Maintain disciplined execution against strategic priorities.

Key Dates

Recommendation

The company is showing signs of operational improvement with increased Adjusted EBITDA and positive trends in the Integrated Care segment. However, the persistent revenue decline, particularly in the BetterHelp segment, and the ongoing net loss warrant a cautious approach. A 'hold' recommendation reflects the balance between these improving operational metrics and the significant challenges that still need to be overcome.

Keywords

virtual care, telehealth, Integrated Care, BetterHelp, mental health, chronic care, health technology, healthcare services